International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic
- PMID: 32241520
- PMCID: PMC7270774
- DOI: 10.1016/j.clon.2020.03.006
International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic
References
-
- Gay H.A., Santiago R., Gil B., Remedios C., Montes P.J., López-Araujo J. 3rd lessons learned from hurricane maria in puerto rico: practical measures to mitigate the impact of a catastrophic natural disaster on radiation oncology patients. Pract Radiat Oncol. 2019 Sep - Oct;9(5):305–321. - PubMed
-
- Kunkler I.H., Williams L.J., Jack W.J., Cameron D.A., Dixon J.M. PRIME II investigators. Breast-conserving surgery with or without irradiationin women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. Lancet Oncol. 2015 Mar;16(3):266–273. doi: 10.1016/S1470-2045(14)71221-5. - DOI - PubMed
-
- Brunt A.M., Haviland J., Sydenham M., Algurafi H., Alhasso A., Bliss P. FAST Phase III RCT of Radiotherapy Hypofractionation for Treatment of Early Breast Cancer: 10-Year Results (CRUKE/04/015) IJROBP. 2018;102(5):1603–1604.
-
- Brunt A.M., Wheatley D., Yarnold J., Somaiah N., Kelly S., Harnett A. FAST-Forward Trial Management Group. Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial. Radiother Oncol. 2016;120:114–118. - PMC - PubMed
-
- Brunt A.M., Haviland J.S., Sydenham M.A., Alhasso A., Bloomfield D., Chan C. OC-0595: FAST-Forward phase 3 RCT of 1-week hypofractionated breast radiotherapy: 3-year normal tissue effects. Radiother Oncol. April 2018;127(Supplement 1):S311–S312.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
